+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Biosurgery Market by Product Type (Hemostats, Sealants & Adhesives, Tissue Grafts), Material Type (Collagen-Based, Fibrin-Based, Gelatin-Based), Resorbability, Application, End User - Global Forecast 2025-2030- Product Image
Biosurgery Market by Product Type (Hemostats, Sealants & Adhesives, Tissue Grafts), Material Type (Collagen-Based, Fibrin-Based, Gelatin-Based), Resorbability, Application, End User - Global Forecast 2025-2030- Product Image
Sale

Biosurgery Market by Product Type (Hemostats, Sealants & Adhesives, Tissue Grafts), Material Type (Collagen-Based, Fibrin-Based, Gelatin-Based), Resorbability, Application, End User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 191 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6082626
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The biosurgery market is advancing quickly as healthcare providers and manufacturers respond to increasing clinical demands, regulatory shifts, and evolving surgical technologies. Senior decision-makers in medtech, life sciences, and hospital procurement are witnessing substantial shifts in clinical practice and global supply chains, driving the need for actionable intelligence and adaptive strategies in the biosurgery sector.

Market Snapshot: Biosurgery Market Size and Growth

The biosurgery market grew from USD 17.15 billion in 2024 to USD 18.58 billion in 2025. It is projected to continue expanding at a compound annual growth rate (CAGR) of 8.48%, ultimately reaching USD 27.96 billion by 2030. This trajectory underscores sustained investment in advanced biomaterials, minimally invasive surgical techniques, and innovative solutions for complex surgical scenarios.

Scope & Segmentation

This report delivers a comprehensive overview and systematic breakdown of the biosurgery market. Key segmentations ensure visibility across the entire value chain and enable data-driven decision making for senior leaders:

  • Product Type: Hemostats, sealants and adhesives, tissue grafts provide distinct functionalities in controlling bleeding, promoting healing, and reconstructing tissue.
  • Material Type: Collagen-based, fibrin-based, gelatin-based, and synthetic materials each influence biocompatibility, clinical acceptance, and regulatory compliance.
  • Resorbability: Nonresorbable and resorbable products (fully and partially resorbable) offer a spectrum of degradation kinetics, essential for matching surgical requirements with patient needs.
  • Application Areas: Cardiovascular surgery, general surgery, minimally invasive and open procedures, and orthopedic surgery are key drivers of product development and portfolio prioritization.
  • End User Environment: Ambulatory surgery centers, hospitals, and specialty clinics—such as dental and ophthalmology—shape demand trends and product adoption cycles.
  • Regional Markets: The Americas, EMEA (Europe, Middle East & Africa), and Asia-Pacific display unique growth patterns, regulatory frameworks, and adoption rates. Countries of interest include the United States, Canada, Brazil, Germany, China, Japan, and others.

Companies tracked and analyzed include leading biosurgery manufacturers and innovators, representing a broad spectrum of global and regional market influences.

Biosurgery Market: Key Takeaways for Decision-Makers

  • Innovation is accelerating with the integration of advanced biomaterials and digital health platforms, enabling more precise, minimally invasive surgical approaches.
  • Collaborations between hospitals, device manufacturers, and research institutions support piloting of cutting-edge technologies and broaden the depth of real-world evidence for new products.
  • Regulatory evolution, including expedited review pathways and global trial harmonization, is reshaping commercialization timelines and global go-to-market strategies.
  • Adoption trends highlight the increasing importance of demonstrating both clinical efficacy and cost-effectiveness, especially as healthcare systems move toward value-based care procurement models.
  • Companies are differentiating through service-based models that combine device sales with perioperative training and outcome analytics to enhance customer engagement and long-term loyalty.

Tariff Impact on Supply Chains and Cost Structures

United States tariff adjustments in 2025 have prompted significant reevaluation across biosurgery supply chains. Higher import duties on key biomaterials drive companies to explore alternative sourcing and increase reliance on synthetic polymers produced domestically. Developers are mitigating cost increases by investing in localized manufacturing and forming partnerships within tariff-exempt zones. Healthcare providers, in turn, are engaging in new contract negotiations and placing increased emphasis on cost-benefit analyses that weigh procedure efficacy against budgetary constraints.

Methodology & Data Sources

This assessment utilizes multidisciplinary data collection: primary interviews with industry experts, practitioner surveys, and in-depth secondary research from peer-reviewed publications and regulatory filings. Quantitative findings are triangulated with hospital procurement and agency data. Rigorous expert review and scenario analysis ensure accuracy and relevance.

Why This Report Matters

  • Equips senior executives with actionable segmentation insights to optimize portfolio management, capitalize on technology convergence, and target critical end-user environments.
  • Enables data-driven planning for navigating evolving regulatory environments and responding to tariff-driven supply chain challenges.
  • Delivers competitive intelligence to inform collaborative R&D, regional go-to-market strategies, and successful commercialization of advanced biosurgical solutions.

Conclusion

The biosurgery market’s evolving landscape requires strategic adaptation to innovation, shifting regulations, and supply chain realities. Comprehensive insights empower leaders to capture growth opportunities and sustain competitive advantage.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Expansion of regenerative cell therapy platforms combined with biosurgical matrices for chronic wound management
5.2. Increasing regulatory approvals for recombinant growth factor based hemostats in gastrointestinal procedures
5.3. Rising partnerships between biomaterial start ups and large medtech players to fast track novel sealants
5.4. Development of next generation antimicrobial bioabsorbable sutures targeting multidrug resistant pathogens
5.5. Integration of 3d bioprinting techniques with biosurgical scaffolds for accelerated tissue regeneration
5.6. Adoption of minimally invasive hemostatic agents in robotic surgery to reduce perioperative bleeding complications
5.7. Integration of artificial intelligence tools in biosurgery to predict patient bleeding risk and optimize agent selection
5.8. Emergence of point of care lyophilized biologic hemostats for rapid deployment in emergency trauma care settings
5.9. Cost containment pressures driving adoption of synthetic biosurgical adhesives over traditional fibrin sealants
5.10. Shift towards customizable biosurgical implants with patient specific scaffolding via 3d printing workflows
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Biosurgery Market, by Product Type
8.1. Introduction
8.2. Hemostats
8.3. Sealants & Adhesives
8.4. Tissue Grafts
9. Biosurgery Market, by Material Type
9.1. Introduction
9.2. Collagen-Based
9.3. Fibrin-Based
9.4. Gelatin-Based
9.5. Synthetic
10. Biosurgery Market, by Resorbability
10.1. Introduction
10.2. Nonresorbable
10.3. Resorbable
10.3.1. Fully Resorbable
10.3.2. Partially Resorbable
11. Biosurgery Market, by Application
11.1. Introduction
11.2. Cardiovascular Surgery
11.2.1. Bypass Surgery
11.2.2. Valve Repair
11.3. General Surgery
11.3.1. Hernia Repair
11.3.2. Wound Repair
11.4. Minimally Invasive Surgery
11.4.1. Endoscopic
11.4.2. Laparoscopic
11.5. Open Surgery
11.6. Orthopedic Surgery
11.6.1. Joint Replacement
11.6.2. Spinal Fusion
12. Biosurgery Market, by End User
12.1. Introduction
12.2. Ambulatory Surgery Centers
12.3. Hospitals
12.4. Specialty Clinics
12.4.1. Dental Clinics
12.4.2. Ophthalmology Clinics
13. Americas Biosurgery Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Biosurgery Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Biosurgery Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Advanced Medical Solutions Group plc
16.3.2. Artivion, Inc.
16.3.3. B. Braun Melsungen AG
16.3.4. Baxter International Inc.
16.3.5. Becton, Dickinson and Company
16.3.6. BioCer Entwicklungs-GmbH
16.3.7. Boston Scientific Corporation
16.3.8. Cardinal Health, Inc.
16.3.9. Corza Medical GmbH
16.3.10. CryoLife, Inc.
16.3.11. CSL Limited
16.3.12. Hemostasis, LLC
16.3.13. Integra LifeSciences Holdings Corporation
16.3.14. Johnson & Johnson
16.3.15. Kuros Bioscience AG
16.3.16. Medtronic plc
16.3.17. Pfizer Inc.
16.3.18. RTI Surgical, Inc.
16.3.19. Samyang Holdings Corporation
16.3.20. Sanofi SA
16.3.21. Smith & Nephew plc
16.3.22. Stryker Corporation
16.3.23. Teleflex Incorporated
16.3.24. Tissue Regenix Ltd
16.3.25. Vivostat A/S
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. BIOSURGERY MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL BIOSURGERY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL BIOSURGERY MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL BIOSURGERY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL BIOSURGERY MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL BIOSURGERY MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL BIOSURGERY MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL BIOSURGERY MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BIOSURGERY MARKET SIZE, BY RESORBABILITY, 2024 VS 2030 (%)
FIGURE 10. GLOBAL BIOSURGERY MARKET SIZE, BY RESORBABILITY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BIOSURGERY MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL BIOSURGERY MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL BIOSURGERY MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL BIOSURGERY MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS BIOSURGERY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS BIOSURGERY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES BIOSURGERY MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES BIOSURGERY MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA BIOSURGERY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA BIOSURGERY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC BIOSURGERY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC BIOSURGERY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. BIOSURGERY MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. BIOSURGERY MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. BIOSURGERY MARKET: RESEARCHAI
FIGURE 26. BIOSURGERY MARKET: RESEARCHSTATISTICS
FIGURE 27. BIOSURGERY MARKET: RESEARCHCONTACTS
FIGURE 28. BIOSURGERY MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. BIOSURGERY MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL BIOSURGERY MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL BIOSURGERY MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL BIOSURGERY MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL BIOSURGERY MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL BIOSURGERY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL BIOSURGERY MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL BIOSURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL BIOSURGERY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL BIOSURGERY MARKET SIZE, BY HEMOSTATS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL BIOSURGERY MARKET SIZE, BY HEMOSTATS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL BIOSURGERY MARKET SIZE, BY SEALANTS & ADHESIVES, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL BIOSURGERY MARKET SIZE, BY SEALANTS & ADHESIVES, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL BIOSURGERY MARKET SIZE, BY TISSUE GRAFTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL BIOSURGERY MARKET SIZE, BY TISSUE GRAFTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL BIOSURGERY MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL BIOSURGERY MARKET SIZE, BY MATERIAL TYPE, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL BIOSURGERY MARKET SIZE, BY COLLAGEN-BASED, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL BIOSURGERY MARKET SIZE, BY COLLAGEN-BASED, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL BIOSURGERY MARKET SIZE, BY FIBRIN-BASED, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL BIOSURGERY MARKET SIZE, BY FIBRIN-BASED, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL BIOSURGERY MARKET SIZE, BY GELATIN-BASED, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL BIOSURGERY MARKET SIZE, BY GELATIN-BASED, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL BIOSURGERY MARKET SIZE, BY SYNTHETIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL BIOSURGERY MARKET SIZE, BY SYNTHETIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL BIOSURGERY MARKET SIZE, BY RESORBABILITY, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL BIOSURGERY MARKET SIZE, BY RESORBABILITY, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL BIOSURGERY MARKET SIZE, BY NONRESORBABLE, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL BIOSURGERY MARKET SIZE, BY NONRESORBABLE, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL BIOSURGERY MARKET SIZE, BY RESORBABLE, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL BIOSURGERY MARKET SIZE, BY RESORBABLE, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL BIOSURGERY MARKET SIZE, BY FULLY RESORBABLE, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL BIOSURGERY MARKET SIZE, BY FULLY RESORBABLE, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL BIOSURGERY MARKET SIZE, BY PARTIALLY RESORBABLE, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL BIOSURGERY MARKET SIZE, BY PARTIALLY RESORBABLE, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL BIOSURGERY MARKET SIZE, BY RESORBABLE, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL BIOSURGERY MARKET SIZE, BY RESORBABLE, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL BIOSURGERY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL BIOSURGERY MARKET SIZE, BY CARDIOVASCULAR SURGERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL BIOSURGERY MARKET SIZE, BY CARDIOVASCULAR SURGERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL BIOSURGERY MARKET SIZE, BY BYPASS SURGERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL BIOSURGERY MARKET SIZE, BY BYPASS SURGERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL BIOSURGERY MARKET SIZE, BY VALVE REPAIR, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL BIOSURGERY MARKET SIZE, BY VALVE REPAIR, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL BIOSURGERY MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL BIOSURGERY MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL BIOSURGERY MARKET SIZE, BY GENERAL SURGERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL BIOSURGERY MARKET SIZE, BY GENERAL SURGERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL BIOSURGERY MARKET SIZE, BY HERNIA REPAIR, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL BIOSURGERY MARKET SIZE, BY HERNIA REPAIR, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL BIOSURGERY MARKET SIZE, BY WOUND REPAIR, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL BIOSURGERY MARKET SIZE, BY WOUND REPAIR, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL BIOSURGERY MARKET SIZE, BY GENERAL SURGERY, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL BIOSURGERY MARKET SIZE, BY GENERAL SURGERY, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL BIOSURGERY MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL BIOSURGERY MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL BIOSURGERY MARKET SIZE, BY ENDOSCOPIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL BIOSURGERY MARKET SIZE, BY ENDOSCOPIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL BIOSURGERY MARKET SIZE, BY LAPAROSCOPIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL BIOSURGERY MARKET SIZE, BY LAPAROSCOPIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL BIOSURGERY MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL BIOSURGERY MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL BIOSURGERY MARKET SIZE, BY OPEN SURGERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL BIOSURGERY MARKET SIZE, BY OPEN SURGERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL BIOSURGERY MARKET SIZE, BY ORTHOPEDIC SURGERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL BIOSURGERY MARKET SIZE, BY ORTHOPEDIC SURGERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL BIOSURGERY MARKET SIZE, BY JOINT REPLACEMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL BIOSURGERY MARKET SIZE, BY JOINT REPLACEMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL BIOSURGERY MARKET SIZE, BY SPINAL FUSION, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL BIOSURGERY MARKET SIZE, BY SPINAL FUSION, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL BIOSURGERY MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL BIOSURGERY MARKET SIZE, BY ORTHOPEDIC SURGERY, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL BIOSURGERY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL BIOSURGERY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL BIOSURGERY MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL BIOSURGERY MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL BIOSURGERY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL BIOSURGERY MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL BIOSURGERY MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL BIOSURGERY MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL BIOSURGERY MARKET SIZE, BY DENTAL CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL BIOSURGERY MARKET SIZE, BY DENTAL CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL BIOSURGERY MARKET SIZE, BY OPHTHALMOLOGY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL BIOSURGERY MARKET SIZE, BY OPHTHALMOLOGY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL BIOSURGERY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL BIOSURGERY MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS BIOSURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS BIOSURGERY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS BIOSURGERY MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS BIOSURGERY MARKET SIZE, BY MATERIAL TYPE, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS BIOSURGERY MARKET SIZE, BY RESORBABILITY, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS BIOSURGERY MARKET SIZE, BY RESORBABILITY, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS BIOSURGERY MARKET SIZE, BY RESORBABLE, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS BIOSURGERY MARKET SIZE, BY RESORBABLE, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS BIOSURGERY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS BIOSURGERY MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS BIOSURGERY MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS BIOSURGERY MARKET SIZE, BY GENERAL SURGERY, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS BIOSURGERY MARKET SIZE, BY GENERAL SURGERY, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS BIOSURGERY MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS BIOSURGERY MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS BIOSURGERY MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS BIOSURGERY MARKET SIZE, BY ORTHOPEDIC SURGERY, 2025-2030 (USD MILLION)
TABLE 107. AMERICAS BIOSURGERY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 108. AMERICAS BIOSURGERY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 109. AMERICAS BIOSURGERY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 110. AMERICAS BIOSURGERY MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 111. AMERICAS BIOSURGERY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 112. AMERICAS BIOSURGERY MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 113. UNITED STATES BIOSURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 114. UNITED STATES BIOSURGERY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 115. UNITED STATES BIOSURGERY MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
TABLE 116. UNITED STATES BIOSURGERY MARKET SIZE, BY MATERIAL TYPE, 2025-2030 (USD MILLION)
TABLE 117. UNITED STATES BIOSURGERY MARKET SIZE, BY RESORBABILITY, 2018-2024 (USD MILLION)
TABLE 118. UNITED STATES BIOSURGERY MARKET SIZE, BY RESORBABILITY, 2025-2030 (USD MILLION)
TABLE 119. UNITED STATES BIOSURGERY MARKET SIZE, BY RESORBABLE, 2018-2024 (USD MILLION)
TABLE 120. UNITED STATES BIOSURGERY MARKET SIZE, BY RESORBABLE, 2025-2030 (USD MILLION)
TABLE 121. UNITED STATES BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 122. UNITED STATES BIOSURGERY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 123. UNITED STATES BIOSURGERY MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2024 (USD MILLION)
TABLE 124. UNITED STATES BIOSURGERY MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2025-2030 (USD MILLION)
TABLE 125. UNITED STATES BIOSURGERY MARKET SIZE, BY GENERAL SURGERY, 2018-2024 (USD MILLION)
TABLE 126. UNITED STATES BIOSURGERY MARKET SIZE, BY GENERAL SURGERY, 2025-2030 (USD MILLION)
TABLE 127. UNITED STATES BIOSURGERY MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2024 (USD MILLION)
TABLE 128. UNITED STATES BIOSURGERY MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2025-2030 (USD MILLION)
TABLE 129. UNITED STATES BIOSURGERY MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2024 (USD MILLION)
TABLE 130. UNITED STATES BIOSURGERY MARKET SIZE, BY ORTHOPEDIC SURGERY, 2025-2030 (USD MILLION)
TABLE 131. UNITED STATES BIOSURGERY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 132. UNITED STATES BIOSURGERY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 133. UNITED STATES BIOSURGERY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 134. UNITED STATES BIOSURGERY MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 135. UNITED STATES BIOSURGERY MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 136. UNITED STATES BIOSURGERY MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 137. CANADA BIOSURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 138. CANADA BIOSURGERY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 139. CANADA BIOSURGERY MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
TABLE 140. CANADA BIOSURGERY MARKET SIZE, BY MATERIAL TYPE, 2025-2030 (USD MILLION)
TABLE 141. CANADA BIOSURGERY MARKET SIZE, BY RESORBABILITY, 2018-2024 (USD MILLION)
TABLE 142. CANADA BIOSURGERY MARKET SIZE, BY RESORBABILITY, 2025-2030 (USD MILLION)
TABLE 143. CANADA BIOSURGERY MARKET SIZE, BY RESORBABLE, 2018-2024 (USD MILLION)
TABLE 144. CANADA BIOSURGERY MARKET SIZE, BY RESORBABLE, 2025-2030 (USD MILLION)
TABLE 145. CANADA BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 146. CANADA BIOSURGERY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 147. CANADA BIOSURGERY MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2024 (USD MILLION)
TABLE 148. CANADA BIOSURGERY MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2025-2030 (USD MILLION)
TABLE 149. CANADA BIOSURGERY MARKET SIZE, BY GENERAL SURGERY, 2018-2024 (USD MILLION)
TABLE 150. CANADA BIOSURGERY MARKET SIZE, BY GENERAL SURGERY, 2025-2030 (USD MILLION)
TABLE 151. CANADA BIOSURGERY MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2024 (USD MILLION)
TABLE 152. CANADA BIOSURGERY MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2025-2030 (USD MILLION)
TABLE 153. CANADA BIOSURGERY MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2024 (USD MILLION)
TABLE 154. CANADA BIOSURGERY MARKET SIZE, BY ORTHOPEDIC SURGERY, 2025-2030 (USD MILLION)
TABLE 155. CANADA BIOSURGERY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 156. CANADA BIOSURGERY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 157. CANADA BIOSURGERY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 158. CANADA BIOSURGERY MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 159. MEXICO BIOSURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 160. MEXICO BIOSURGERY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 161. MEXICO BIOSURGERY MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
TABLE 162. MEXICO BIOSURGERY MARKET SIZE, BY MATERIAL TYPE, 2025-2030 (USD MILLION)
TABLE 163. MEXICO BIOSURGERY MARKET SIZE, BY RESORBABILITY, 2018-2024 (USD MILLION)
TABLE 164. MEXICO BIOSURGERY MARKET SIZE, BY RESORBABILITY, 2025-2030 (USD MILLION)
TABLE 165. MEXICO BIOSURGERY MARKET SIZE, BY RESORBABLE, 2018-2024 (USD MILLION)
TABLE 166. MEXICO BIOSURGERY MARKET SIZE, BY RESORBABLE, 2025-2030 (USD MILLION)
TABLE 167. MEXICO BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 168. MEXICO BIOSURGERY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 169. MEXICO BIOSURGERY MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2024 (USD MILLION)
TABLE 170. MEXICO BIOSURGERY MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2025-2030 (USD MILLION)
TABLE 171. MEXICO BIOSURGERY MARKET SIZE, BY GENERAL SURGERY, 2018-2024 (USD MILLION)
TABLE 172. MEXICO BIOSURGERY MARKET SIZE, BY GENERAL SURGERY, 2025-2030 (USD MILLION)
TABLE 173. MEXICO BIOSURGERY MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2024 (USD MILLION)
TABLE 174. MEXICO BIOSURGERY MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2025-2030 (USD MILLION)
TABLE 175. MEXICO BIOSURGERY MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2024 (USD MILLION)
TABLE 176. MEXICO BIOSURGERY MARKET SIZE, BY ORTHOPEDIC SURGERY, 2025-2030 (USD MILLION)
TABLE 177. MEXICO BIOSURGERY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 178. MEXICO BIOSURGERY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 179. MEXICO BIOSURGERY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 180. MEXICO BIOSURGERY MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 181. BRAZIL BIOSURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 182. BRAZIL BIOSURGERY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 183. BRAZIL BIOSURGERY MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
TABLE 184. BRAZIL BIOSURGERY MARKET SIZE, BY MATERIAL TYPE, 2025-2030 (USD MILLION)
TABLE 185. BRAZIL BIOSURGERY MARKET SIZE, BY RESORBABILITY, 2018-2024 (USD MILLION)
TABLE 186. BRAZIL BIOSURGERY MARKET SIZE, BY RESORBABILITY, 2025-2030 (USD MILLION)
TABLE 187. BRAZIL BIOSURGERY MARKET SIZE, BY RESORBABLE, 2018-2024 (USD MILLION)
TABLE 188. BRAZIL BIOSURGERY MARKET SIZE, BY RESORBABLE, 2025-2030 (USD MILLION)
TABLE 189. BRAZIL BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 190. BRAZIL BIOSURGERY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 191. BRAZIL BIOSURGERY MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2024 (USD MILLION)
TABLE 192. BRAZIL BIOSURGERY MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2025-2030 (USD MILLION)
TABLE 193. BRAZIL BIOSURGERY MARKET SIZE, BY GENERAL SURGERY, 2018-2024 (USD MILLION)
TABLE 194. BRAZIL BIOSURGERY MARKET SIZE, BY GENERAL SURGERY, 2025-2030 (USD MILLION)
TABLE 195. BRAZIL BIOSURGERY MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2024 (USD MILLION)
TABLE 196. BRAZIL BIOSURGERY MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2025-2030 (USD MILLION)
TABLE 197. BRAZIL BIOSURGERY MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2024 (USD MILLION)
TABLE 198. BRAZIL BIOSURGERY MARKET SIZE, BY ORTHOPEDIC SURGERY, 2025-2030 (USD MILLION)
TABLE 199. BRAZIL BIOSURGERY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 200. BRAZIL BIOSURGERY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 201. BRAZIL BIOSURGERY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 202. BRAZIL BIOSURGERY MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 203. ARGENTINA BIOSURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 204. ARGENTINA BIOSURGERY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 205. ARGENTINA BIOSURGERY MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
TABLE 206. ARGENTINA BIOSURGERY MARKET SIZE, BY MATERIAL TYPE, 2025-2030 (USD MILLION)
TABLE 207. ARGENTINA BIOSURGERY MARKET SIZE, BY RESORBABILITY, 2018-2024 (USD MILLION)
TABLE 208. ARGENTINA BIOSURGERY MARKET SIZE, BY RESORBABILITY, 2025-2030 (USD MILLION)
TABLE 209. ARGENTINA BIOSURGERY MARKET SIZE, BY RESORBABLE, 2018-2024 (USD MILLION)
TABLE 210. ARGENTINA BIOSURGERY MARKET SIZE, BY RESORBABLE, 2025-2030 (USD MILLION)
TABLE 211. ARGENTINA BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 212. ARGENTINA BIOSURGERY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 213. ARGENTINA BIOSURGERY MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2024 (USD MILLION)
TABLE 214. ARGENTINA BIOSURGERY MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2025-2030 (USD MILLION)
TABLE 215. ARGENTINA BIOSURGERY MARKET SIZE, BY GENERAL SURGERY, 2018-2024 (USD MILLION)
TABLE 216. ARGENTINA BIOSURGERY MARKET SIZE, BY GENERAL SURGERY, 2025-2030 (USD MILLION)
TABLE 217. ARGENTINA BIOSURGERY MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2024 (USD MILLION)
TABLE 218. ARGENTINA BIOSURGERY MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2025-2030 (USD MILLION)
TABLE 219. ARGENTINA BIOSURGERY MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2024 (USD MILLION)
TABLE 220. ARGENTINA BIOSURGERY MARKET SIZE, BY ORTHOPEDIC SURGERY, 2025-2030 (USD MILLION)
TABLE 221. ARGENTINA BIOSURGERY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 222. ARGENTINA BIOSURGERY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 223. ARGENTINA BIOSURGERY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 224. ARGENTINA BIOSURGERY MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 225. EUROPE, MIDDLE EAST & AFRICA BIOSURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 226. EUROPE, MIDDLE EAST & AFRICA BIOSURGERY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 227. EUROPE, MIDDLE EAST & AFRICA BIOSURGERY MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
TABLE 228. EUROPE, MIDDLE EAST & AFRICA BIOSURGERY MARKET SIZE, BY MATERIAL TYPE, 2025-2030 (USD MILLION)
TABLE 229. EUROPE, MIDDLE EAST & AFRICA BIOSURGERY MARKET SIZE, BY RESORBABILITY, 2018-2024 (USD MILLION)
TABLE 230. EUROPE, MIDDLE EAST & AFRICA BIOSURGERY MARKET SIZE, BY RESORBABILITY, 2025-2030 (USD MILLION)
TABLE 231. EUROPE, MIDDLE EAST & AFRICA BIOSURGERY MARKET SIZE, BY RESORBABLE, 2018-2024 (USD MILLION)
TABLE 232. EUROPE, MIDDLE EAST & AFRICA BIOSURGERY MARKET SIZE, BY RESORBABLE, 2025-2030 (USD MILLION)
TABLE 233. EUROPE, MIDDLE EAST & AFRICA BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 234. EUROPE, MIDDLE EAST & AFRICA BIOSURGERY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 235. EUROPE, MIDDLE EAST & AFRICA BIOSURGERY MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2024 (USD MILLION)
TABLE 236. EUROPE, MIDDLE EAST & AFRICA BIOSURGERY MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2025-2030 (USD MILLION)
TABLE 237. EUROPE, MIDDLE EAST & AFRICA BIOSURGERY MARKET SIZE, BY GENERAL SURGERY, 2018-2024 (USD MILLION)
TABLE 238. EUROPE, MIDDLE EAST & AFRICA BIOSURGERY MARKET SIZE, BY GENERAL SURGERY, 2025-2030 (USD MILLION)
TABLE 239. EUROPE, MIDDLE EAST & AFRICA BIOSURGERY MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2024 (USD MILLION)
TABLE 240. EUROPE, MIDDLE EAST & AFRICA BIOSURGERY MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2025-2030 (USD MILLION)
TABLE 241. EUROPE, MIDDLE EAST & AFRICA BIOSURGERY MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2024 (USD MILLION)
TABLE 242. EUROPE, MIDDLE EAST & AFRICA BIOSURGERY MARKET SIZE, BY ORTHOPEDIC SURGERY, 2025-2030 (USD MILLION)
TABLE 243. EUROPE, MIDDLE EAST & AFRICA BIOSURGERY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 244. EUROPE, MIDDLE EAST & AFRICA BIOSURGERY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 245. EUROPE, MIDDLE EAST & AFRICA BIOSURGERY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 246. EUROPE, MIDDLE EAST & AFRICA BIOSURGERY MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 247. EUROPE, MIDDLE EAST & AFRICA BIOSURGERY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 248. EUROPE, MIDDLE EAST & AFRICA BIOSURGERY MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 249. UNITED KINGDOM BIOSURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 250. UNITED KINGDOM BIOSURGERY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 251. UNITED KINGDOM BIOSURGERY MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
TABLE 252. UNITED KINGDOM BIOSURGERY MARKET SIZE, BY MATERIAL TYPE, 2025-2030 (USD MILLION)
TABLE 253. UNITED KINGDOM BIOSURGERY MARKET SIZE, BY RESORBABILITY, 2018-2024 (USD MILLION)
TABLE 254. UNITED KINGDOM BIOSURGERY MARKET SIZE, BY RESORBABILITY, 2025-2030 (USD MILLION)
TABLE 255. UNITED KINGDOM BIOSURGERY MARKET SIZE, BY RESORBABLE, 2018-2024 (USD MILLION)
TABLE 256. UNITED KINGDOM BIOSURGERY MARKET SIZE, BY RESORBABLE, 2025-2030 (USD MILLION)
TABLE 257. UNITED KINGDOM BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 258. UNITED KINGDOM BIOSURGERY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 259. UNITED KINGDOM BIOSURGERY MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2024 (USD MILLION)
TABLE 260. UNITED KINGDOM BIOSURGERY MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2025-2030 (USD MILLION)
TABLE 261. UNITED KINGDOM BIOSURGERY MARKET SIZE, BY GENERAL SURGERY, 2018-2024 (USD MILLION)
TABLE 262. UNITED KINGDOM BIOSURGERY MARKET SIZE, BY GENERAL SURGERY, 2025-2030 (USD MILLION)
TABLE 263. UNITED KINGDOM BIOSURGERY MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2024 (USD MILLION)
TABLE 264. UNITED KINGDOM BIOSURGERY MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2025-2030 (USD MILLION)
TABLE 265. UNITED KINGDOM BIOSURGERY MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2024 (USD MILLION)
TABLE 266. UNITED KINGDOM BIOSURGERY MARKET SIZE, BY ORTHOPEDIC SURGERY, 2025-2030 (USD MILLION)
TABLE 267. UNITED KINGDOM BIOSURGERY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 268. UNITED KINGDOM BIOSURGERY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 269. UNITED KINGDOM BIOSURGERY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 270. UNITED KINGDOM BIOSURGERY MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 271. GERMANY BIOSURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 272. GERMANY BIOSURGERY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 273. GERMANY BIOSURGERY MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
TABLE 274. GERMANY BIOSURGERY MARKET SIZE, BY MATERIAL TYPE, 2025-2030 (USD MILLION)
TABLE 275. GERMANY BIOSURGERY MARKET SIZE, BY RESORBABILITY, 2018-2024 (USD MILLION)
TABLE 276. GERMANY BIOSURGERY MARKET SIZE, BY RESORBABILITY, 2025-2030 (USD MILLION)
TABLE 277. GERMANY BIOSURGERY MARKET SIZE, BY RESORBABLE, 2018-2024 (USD MILLION)
TABLE 278. GERMANY BIOSURGERY MARKET SIZE, BY RESORBABLE, 2025-2030 (USD MILLION)
TABLE 279. GERMANY BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 280. GERMANY BIOSURGERY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 281. GERMANY BIOSURGERY MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2024 (USD MILLION)
TABLE 282. GERMANY BIOSURGERY MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2025-2030 (USD MILLION)
TABLE 283. GERMANY BIOSURGERY MARKET SIZE, BY GENERAL SURGERY, 2018-2024 (USD MILLION)
TABLE 284. GERMANY BIOSURGERY MARKET SIZE, BY GENERAL SURGERY, 2025-2030 (USD MILLION)
TABLE 285. GERMANY BIOSURGERY MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2024 (USD MILLION)
TABLE 286. GERMANY BIOSURGERY MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2025-2030 (USD MILLION)
TABLE 287. GERMANY BIOSURGERY MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2024 (USD MILLION)
TABLE 288. GERMANY BIOSURGERY MARKET SIZE, BY ORTHOPEDIC SURGERY, 2025-2030 (USD MILLION)
TABLE 289. GERMANY BIOSURGERY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 290. GERMANY BIOSURGERY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 291. GERMANY BIOSURGERY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 292. GERMANY BIOSURGERY MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 293. FRANCE BIOSURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 294. FRANCE BIOSURGERY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 295. FRANCE BIOSURGERY MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
TABLE 296. FRANCE BIOSURGERY MARKET SIZE, BY MATERIAL TYPE, 2025-2030 (USD MILLION)
TABLE 297. FRANCE BIOSURGERY MARKET SIZE, BY RESORBABILITY, 2018-2024 (USD MILLION)
TABLE 298. FRANCE BIOSURGERY MARKET SIZE, BY RESORBABILITY, 2025-2030 (USD MILLION)
TABLE 299. FRANCE BIOSURGERY MARKET SIZE, BY RESORBABLE, 2018-2024 (USD MILLION)
TABLE 300. FRANCE BIOSURGERY MARKET SIZE, BY RESORBABLE, 2025-2030 (USD MILLION)
TABLE 301. FRANCE BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 302. FRANCE BIOSURGERY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 303. FRANCE BIOSURGERY MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2024 (USD MILLION)
TABLE 304. FRANCE BIOSURGERY MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2025-2030 (USD MILLION)
TABLE 305. FRANCE BIOSURGERY MARKET SIZE, BY GENERAL SURGERY, 2018-2024 (USD MILLION)
TABLE 306. FRANCE BIOSURGERY MARKET SIZE, BY GENERAL SURGERY, 2025-2030 (USD MILLION)
TABLE 307. FRANCE BIOSURGERY MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2024 (USD MILLION)
TABLE 308. FRANCE BIOSURGERY MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2025-2030 (USD MILLION)
TABLE 309. FRANCE BIOSURGERY MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2024 (USD MILLION)
TABLE 310. FRANCE BIOSURGERY MARKET SIZE, BY ORTHOPEDIC SURGERY, 2025-2030 (USD MILLION)
TABLE 311. FRANCE BIOSURGERY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 312. FRANCE BIOSURGERY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 313. FRANCE BIOSURGERY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 314. FRANCE BIOSURGERY MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 315. RUSSIA BIOSURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 316. RUSSIA BIOSURGERY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 317. RUSSIA BIOSURGERY MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
TABLE 318. RUSSIA BIOSURGERY MARKET SIZE, BY MATERIAL TYPE, 2025-2030 (USD MILLION)
TABLE 319. RUSSIA BIOSURGERY MARKET SIZE, BY RESORBABILITY, 2018-2024 (USD MILLION)
TABLE 320. RUSSIA BIOSURGERY MARKET SIZE, BY RESORBABILITY, 2025-2030 (USD MILLION)
TABLE 321. RUSSIA BIOSURGERY MARKET SIZE, BY RESORBABLE, 2018-2024 (USD MILLION)
TABLE 322. RUSSIA BIOSURGERY MARKET SIZE, BY RESORBABLE, 2025-2030 (USD MILLION)
TABLE 323. RUSSIA BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 324. RUSSIA BIOSURGERY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 325. RUSSIA BIOSURGERY MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2024 (USD MILLION)
TABLE 326. RUSSIA BIOSURGERY MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2025-2030 (USD MILLION)
TABLE 327. RUSSIA BIOSURGERY MARKET SIZE, BY GENERAL SURGERY, 2018-2024 (USD MILLION)
TABLE 328. RUSSIA BIOSURGERY MARKET SIZE, BY GENERAL SURGERY, 2025-2030 (USD MILLION)
TABLE 329. RUSSIA BIOSURGERY MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2024 (USD MILLION)
TABLE 330. RUSSIA BIOSURGERY MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2025-2030 (USD MILLION)
TABLE 331. RUSSIA BIOSURGERY MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2024 (USD MILLION)
TABLE 332. RUSSIA BIOSURGERY MARKET SIZE, BY ORTHOPEDIC SURGERY, 2025-2030 (USD MILLION)
TABLE 333. RUSSIA BIOSURGERY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 334. RUSSIA BIOSURGERY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 335. RUSSIA BIOSURGERY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 336. RUSSIA BIOSURGERY MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 337. ITALY BIOSURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 338. ITALY BIOSURGERY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 339. ITALY BIOSURGERY MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
TABLE 340. ITALY BIOSURGERY MARKET SIZE, BY MATERIAL TYPE, 2025-2030 (USD MILLION)
TABLE 341. ITALY BIOSURGERY MARKET SIZE, BY RESORBABILITY, 2018-2024 (USD MILLION)
TABLE 342. ITALY BIOSURGERY MARKET SIZE, BY RESORBABILITY, 2025-2030 (USD MILLION)
TABLE 343. ITALY BIOSURGERY MARKET SIZE, BY RESORBABLE, 2018-2024 (USD MILLION)
TABLE 344. ITALY BIOSURGERY MARKET SIZE, BY RESORBABLE, 2025-2030 (USD MILLION)
TABLE 345. ITALY BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 346. ITALY BIOSURGERY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 347. ITALY BIOSURGERY MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2024 (USD MILLION)
TABLE 348. ITALY BIOSURGERY MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2025-2030 (USD MILLION)
TABLE 349. ITALY BIOSURGERY MARKET SIZE, BY GENERAL SURGERY, 2018-2024 (USD MILLION)
TABLE 350. ITALY BIOSURGERY MARKET SIZE, BY GENERAL SURGERY, 2025-2030 (USD MILLION)
TABLE 351. ITALY BIOSURGERY MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2024 (USD MILLION)
TABLE 352. ITALY BIOSURGERY MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2025-2030 (USD MILLION)
TABLE 353. ITALY BIOSURGERY MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2024 (USD MILLION)
TABLE 354. ITALY BIOSURGERY MARKET SIZE, BY ORTHOPEDIC SURGERY, 2025-2030 (USD MILLION)
TABLE 355. ITALY BIOSURGERY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 356. ITALY BIOSURGERY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 357. ITALY BIOSURGERY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 358. ITALY BIOSURGERY MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 359. SPAIN BIOSURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 360. SPAIN BIOSURGERY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 361. SPAIN BIOSURGERY MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
TABLE 362. SPAIN BIOSURGERY MARKET SIZE, BY MATERIAL TYPE, 2025-2030 (USD MILLION)
TABLE 363. SPAIN BIOSURGERY MARKET SIZE, BY RESORBABILITY, 2018-2024 (USD MILLION)
TABLE 364. SPAIN BIOSURGERY MARKET SIZE, BY RESORBABILITY, 2025-2030 (USD MILLION)
TABLE 365. SPAIN BIOSURGERY MARKET SIZE, BY RESORBABLE, 2018-2024 (USD MILLION)
TABLE 366. SPAIN BIOSURGERY MARKET SIZE, BY RESORBABLE, 2025-2030 (USD MILLION)

Samples

Loading
LOADING...

Companies Mentioned

  • Advanced Medical Solutions Group plc
  • Artivion, Inc.
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Becton, Dickinson and Company
  • BioCer Entwicklungs‑GmbH
  • Boston Scientific Corporation
  • Cardinal Health, Inc.
  • Corza Medical GmbH
  • CryoLife, Inc.
  • CSL Limited
  • Hemostasis, LLC
  • Integra LifeSciences Holdings Corporation
  • Johnson & Johnson
  • Kuros Bioscience AG
  • Medtronic plc
  • Pfizer Inc.
  • RTI Surgical, Inc.
  • Samyang Holdings Corporation
  • Sanofi SA
  • Smith & Nephew plc
  • Stryker Corporation
  • Teleflex Incorporated
  • Tissue Regenix Ltd
  • Vivostat A/S

Table Information

Report AttributeDetails
No. of Pages191
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 18.58 Billion
Forecasted Market Value ( USD ) by 2030 $ 27.96 Billion
Compound Annual Growth Rate8.4%
Regions CoveredGlobal
No. of Companies Mentioned25

Related Topics

Related Reports

Biosurgery Market by Product (Bone Graft Substitutes, Sealants (Natural (Gelatin, Collagen)), Hemostatic Agents, Soft-tissue Attachments (Synthetic, Biological)), Application (Orthopedic, Urological), End User (Hospitals, ASCs) - Global Forecast to 2030 - Product Image

Biosurgery Market by Product (Bone Graft Substitutes, Sealants (Natural (Gelatin, Collagen)), Hemostatic Agents, Soft-tissue Attachments (Synthetic, Biological)), Application (Orthopedic, Urological), End User (Hospitals, ASCs) - Global Forecast to 2030

  • Report
  • 414 Pages
  • Global
From
Biosurgery Market Report by Product, Source, Application, End User, and Region 2024-2032 - Product Image

Biosurgery Market Report by Product, Source, Application, End User, and Region 2024-2032

  • Report
  • 146 Pages
  • Global
From
Biosurgery - Global Strategic Business Report - Product Image

Biosurgery - Global Strategic Business Report

  • Report
  • 179 Pages
  • Global
From
Biosurgery Market Size, Share and Trends Analysis Report by Product (Surgical Sealants, Hemostatic Agents, Adhesion Barriers, Soft Tissue Attachments), Application (General Surgery, Orthopedic Surgery), and Region 2024-2030 - Product Image

Biosurgery Market Size, Share and Trends Analysis Report by Product (Surgical Sealants, Hemostatic Agents, Adhesion Barriers, Soft Tissue Attachments), Application (General Surgery, Orthopedic Surgery), and Region 2024-2030

  • Report
  • 100 Pages
  • Global
From
Biosurgery Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type - Product Image

Biosurgery Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type

  • Report
  • 122 Pages
  • Global
From

About the Biosurgery Market

Biosurgery is a rapidly growing field of medical technology that focuses on the use of biological materials to repair, replace, or supplement damaged or missing tissue. It is used in a variety of surgical procedures, including reconstructive surgery, orthopedic surgery, and plastic surgery. Biosurgery products are designed to provide a more natural and effective solution to tissue repair and regeneration. These products are often made from biocompatible materials, such as collagen, hyaluronic acid, and other proteins, and are designed to be minimally invasive and to reduce the risk of infection. Biosurgery products are used in a variety of surgical procedures, including wound healing, tissue engineering, and regenerative medicine. They are also used to treat a variety of conditions, such as burns, ulcers, and hernias. Biosurgery products are also used in cosmetic surgery, such as breast augmentation and facial reconstruction. Some of the companies in the biosurgery market include Allergan, Baxter, Bausch Health, Covidien, Johnson & Johnson, Medtronic, and Smith & Nephew. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.